Human Brain Tumor—Derived Cell Lines: Growth Rate Reduced by Human Fibroblast Interferon
- 18 February 1983
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 219 (4586) , 881-883
- https://doi.org/10.1126/science.6401866
Abstract
The biological response modifier human beta-interferon had pronounced antigrowth effects on various histologic types of human brain tumor cells but no effects on a nontransformed cell line, MRC-5. The cultures of brain tumor cells showed severe alterations indicative of cell injury and death after exposure to beta-interferon for 2 to 6 days. Similar results were obtained with cells freshly explanted from human brain tumors. The results indicate that it may be possible to use fresh, explanted tumor tissue to identify patients who might benefit from therapy with beta-interferon.This publication has 10 references indexed in Scilit:
- Clinical Use of Interferons: Central Nervous System DisordersPublished by Springer Nature ,1984
- Phase I-II Trials of Poly(ICLC) in Malignant Brain Tumor PatientsJournal of Interferon Research, 1982
- Effects of intralesional interferon on neuroblastoma: Changes in histology and DNA content distribution of tumor massesCancer, 1981
- Natural Killer Cells: Their Roles in Defenses Against DiseaseScience, 1981
- Block of a glioma cell line in S by interferonInternational Journal of Cancer, 1981
- [50] Antiproliferative assay for human interferonsPublished by Elsevier ,1981
- Antiproliferative effect of interferon on a Burkitt's lymphoma cell lineExperimental Cell Research, 1980
- SUCCESSFUL TREATMENT OF NASOPHARYNGEAL CARCINOMA WITH INTERFERONThe Lancet, 1980
- ANNOUNCEMENT INTERFERON NOMENCLATUREJournal of Interferon Research, 1980
- Noncycling Tumor Cells Are Sensitive Targets for the Antiproliferative Activity of Human InterferonScience, 1979